ES2039666T3 - Concentrado de proteinas coagulables por la trombina, su procedimiento de obtencion y su utilizacion terapeutica. - Google Patents

Concentrado de proteinas coagulables por la trombina, su procedimiento de obtencion y su utilizacion terapeutica.

Info

Publication number
ES2039666T3
ES2039666T3 ES198888401961T ES88401961T ES2039666T3 ES 2039666 T3 ES2039666 T3 ES 2039666T3 ES 198888401961 T ES198888401961 T ES 198888401961T ES 88401961 T ES88401961 T ES 88401961T ES 2039666 T3 ES2039666 T3 ES 2039666T3
Authority
ES
Spain
Prior art keywords
concentrate
thrombine
procedure
obtaining
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888401961T
Other languages
English (en)
Inventor
Myriana Burnouf
Thierry Burnouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Regional de Transfusion Sanguine de Lille
Original Assignee
Centre Regional de Transfusion Sanguine de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional de Transfusion Sanguine de Lille filed Critical Centre Regional de Transfusion Sanguine de Lille
Application granted granted Critical
Publication of ES2039666T3 publication Critical patent/ES2039666T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CONCENTRADO DE PROTEINAS COAGULANTES POR LA TROMBINA, QUE PRESENTA UN CONTENIDO EN FIBRINOGENO SUPERIOR A 70% Y UNA CANTIDAD SUFICIENTE DE FACTOR XIII ENDOGENO. PUEDE SER SOLUBILIZADO A TEMPERATURA AMBIENTE. SU PREPARACION HACE INTERVENIR AL MENOS UNA ETAPA DE PRECIPITACION EN FRIO CON ETANOL DILUIDO Y UTILIZA COMO PRODUCTO DE PARTIDA EL PLASMA TOTAL. EL CONCENTRADO PERMITE ESPECIALMENTE OBTENER UN FIBRINOGENO INYECTABLE Y UNA COLA BIOLOGICA.
ES198888401961T 1987-07-30 1988-07-28 Concentrado de proteinas coagulables por la trombina, su procedimiento de obtencion y su utilizacion terapeutica. Expired - Lifetime ES2039666T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8710798A FR2618784B1 (fr) 1987-07-30 1987-07-30 Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique

Publications (1)

Publication Number Publication Date
ES2039666T3 true ES2039666T3 (es) 1993-10-01

Family

ID=9353711

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888401961T Expired - Lifetime ES2039666T3 (es) 1987-07-30 1988-07-28 Concentrado de proteinas coagulables por la trombina, su procedimiento de obtencion y su utilizacion terapeutica.

Country Status (10)

Country Link
EP (1) EP0305243B1 (es)
JP (1) JP2787317B2 (es)
AT (1) ATE73341T1 (es)
CA (1) CA1341376C (es)
DE (1) DE3869018D1 (es)
DK (1) DK173568B1 (es)
ES (1) ES2039666T3 (es)
FR (1) FR2618784B1 (es)
GR (1) GR3004047T3 (es)
NO (1) NO174929C (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0431072Y2 (es) * 1988-03-14 1992-07-27
FR2639958B1 (fr) * 1988-12-06 1992-08-21 Lille Transfusion Sanguine Support biologique pour cultures cellulaires constitue de proteines plasmatiques coagulees par la thrombine, son utilisation pour la culture des keratinocytes, leur recuperation et leur transport a des fins d'utilisation therapeutique
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7208179B1 (en) 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
DE4202667C1 (es) 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
WO1994002183A1 (en) * 1992-07-27 1994-02-03 Haemacure Biotech Inc. Biocompatible surgical implant
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
DE69734557T2 (de) 1996-03-15 2006-07-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Sprühvorrichtung zum aufbringen von gewebeklebstoff
WO1998055140A1 (en) * 1997-06-05 1998-12-10 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
FR2894831B1 (fr) 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
FR2952641B1 (fr) 2009-11-18 2012-01-13 Lfb Biomedicaments Procede de traitement du plasma sanguin comprenant une etape de lavage par dispersion
FR3032621A1 (fr) 2015-02-13 2016-08-19 Lab Francais Du Fractionnement Colle biologique et son utilisation comme medicament
EP3307237A1 (en) 2015-06-12 2018-04-18 Laboratoire Français du Fractionnement et des Biotechnologies Injectable composition of factor vii and fillers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156681A (en) * 1974-03-28 1979-05-29 Plasmesco Ag Process for isolating albumin from blood
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3171072D1 (en) * 1981-06-25 1985-07-25 Stroetmann M Serapharm Enriched plasma derivative for promoting wound sealing and wound covering
US4374061A (en) * 1981-07-27 1983-02-15 Center For Blood Research, Inc. Means and methods for purifying Clq, Clr and Cls
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE3228502A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung des c1-inaktivators und seine verwendung
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives

Also Published As

Publication number Publication date
ATE73341T1 (de) 1992-03-15
CA1341376C (fr) 2002-07-16
JP2787317B2 (ja) 1998-08-13
DK424188D0 (da) 1988-07-29
GR3004047T3 (es) 1993-03-31
EP0305243A1 (fr) 1989-03-01
EP0305243B1 (fr) 1992-03-11
NO174929B (no) 1994-04-25
DK173568B1 (da) 2001-03-19
NO174929C (no) 1994-08-03
NO883342L (no) 1989-01-31
NO883342D0 (no) 1988-07-28
FR2618784B1 (fr) 1990-04-06
DK424188A (da) 1989-01-31
JPH02114A (ja) 1990-01-05
DE3869018D1 (de) 1992-04-16
FR2618784A1 (fr) 1989-02-03

Similar Documents

Publication Publication Date Title
ES2039666T3 (es) Concentrado de proteinas coagulables por la trombina, su procedimiento de obtencion y su utilizacion terapeutica.
FI101381B1 (fi) Nukleotidisekvenssi ja menetelmä polypeptidin HSA(1-387) tuottamiseksi
NO905264L (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
DE3580283D1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
ATE159297T1 (de) Expression von menschlichen serumalbumin in methylotrophischen hefen
DE69224768D1 (de) Expression von menschlichen Serum-Albuminen in Pichia pastoris
AU1170588A (en) Methods and deoxyribonucleic acid for the preparation of tissue factor protein
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
DE69034254D1 (de) A-pdgf-rezeptor und dessen verwendung
NO180636C (no) Fremgangsmåte for fremstilling av et rent O-glycosylert IGF-1
DE68908913T2 (de) Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.
DE69018755T2 (de) Verfahren zur Herstellung von 3-(L-Pyroglutamyl)-L-thiazolidin-4-carbonsäure-Derivaten.
ATE127842T1 (de) Megakaryocytopoietin, seine herstellung und benutzung.
ATE109509T1 (de) Anticoagulatorisches protein pp4-x, seine herstellung und verwendung.
ATE57835T1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
KR910016339A (ko) Pp4-델타, 이의 제조방법 및 용도

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 305243

Country of ref document: ES